Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03548402 · ClinicalTrials.gov registry record · NA

Acceptance and Commitment Therapy for Nonsuicidal Self-injury

A NA study, sponsored by Southern Methodist University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03548402: Completed NA study, sponsored by Southern Methodist University.

NCT03548402 is a NA study that has completed, run by Southern Methodist University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03548402, a NA study, has completed, sponsored by Southern Methodist University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The goal of this study is to evaluate the effectiveness of Acceptance and Commitment Therapy (ACT) for individuals who engage in nonsuicidal self-injury(NSSI) and have comorbid anxiety. With the data collected from the study, the investigators will test the following hypotheses: Acceptance and commitment therapy will lead to reductions in anxiety and self-harm behaviors in non-suicidal self-injury individuals.

Primary Outcome

Whether there is a decrease in the participants self-reported urge to self-injure as measured by the Alexian Brothers Urge to Self-Injure Scale (ABUSI). Responses are on a 7-point scale with a maximum total score of 30 and higher scores reflecting more intense urges to self-injure.

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy (ACT)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2012-03-19
Est. Completion 2015-05
Phase NA
Southern Methodist University

17 total trials

What the finished NCT03548402 record still lists

NCT03548402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Acceptance and Commitment Therapy (ACT) is the first listed.

NCT03548402 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03548402 about?

NCT03548402 is a clinical study titled "Acceptance and Commitment Therapy for Nonsuicidal Self-injury". The goal of this study is to evaluate the effectiveness of Acceptance and Commitment Therapy (ACT) for individuals who engage in nonsuicidal self-injury(NSSI) and have comorbid anxiety. With the data collected from the study, the investigators will test the following hypotheses: Acceptance and com...

What is the current status of trial NCT03548402?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2012-03-19. Estimated completion is 2015-05.

What interventions are being tested in trial NCT03548402?

The interventions under investigation include: Acceptance and Commitment Therapy (ACT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03548402?

This trial is sponsored by Southern Methodist University, which has 17 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03548402's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03548402, the US trial registry maintained by the National Library of Medicine. NCT03548402 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.